Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) Return on Equity (2022 - 2025)

Historic Return on Equity for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to 3.16%.

  • Lucid Diagnostics' Return on Equity rose 8500.0% to 3.16% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.16%, marking a year-over-year increase of 8500.0%. This contributed to the annual value of 29.56% for FY2024, which is 244800.0% down from last year.
  • Latest data reveals that Lucid Diagnostics reported Return on Equity of 3.16% as of Q3 2025, which was up 8500.0% from 44.47% recorded in Q2 2025.
  • Lucid Diagnostics' 5-year Return on Equity high stood at 2.22% for Q4 2022, and its period low was 8832.14% during Q1 2025.
  • In the last 4 years, Lucid Diagnostics' Return on Equity had a median value of 5.23% in 2023 and averaged 779.06%.
  • As far as peak fluctuations go, Lucid Diagnostics' Return on Equity skyrocketed by 4221600bps in 2024, and later tumbled by -88223300bps in 2025.
  • Quarter analysis of 4 years shows Lucid Diagnostics' Return on Equity stood at 2.22% in 2022, then plummeted by -19257bps to 429.93% in 2023, then surged by 98bps to 7.76% in 2024, then surged by 59bps to 3.16% in 2025.
  • Its Return on Equity stands at 3.16% for Q3 2025, versus 44.47% for Q2 2025 and 8832.14% for Q1 2025.